1. Home
  2. NVCR vs AVPT Comparison

NVCR vs AVPT Comparison

Compare NVCR & AVPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • AVPT
  • Stock Information
  • Founded
  • NVCR 2000
  • AVPT 2001
  • Country
  • NVCR Jersey
  • AVPT United States
  • Employees
  • NVCR N/A
  • AVPT N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • AVPT Computer Software: Prepackaged Software
  • Sector
  • NVCR Health Care
  • AVPT Technology
  • Exchange
  • NVCR Nasdaq
  • AVPT Nasdaq
  • Market Cap
  • NVCR 1.8B
  • AVPT 2.3B
  • IPO Year
  • NVCR 2015
  • AVPT N/A
  • Fundamental
  • Price
  • NVCR $17.49
  • AVPT $12.46
  • Analyst Decision
  • NVCR Buy
  • AVPT Buy
  • Analyst Count
  • NVCR 5
  • AVPT 4
  • Target Price
  • NVCR $26.60
  • AVPT $12.75
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • AVPT 510.6K
  • Earning Date
  • NVCR 10-30-2024
  • AVPT 11-07-2024
  • Dividend Yield
  • NVCR N/A
  • AVPT N/A
  • EPS Growth
  • NVCR N/A
  • AVPT N/A
  • EPS
  • NVCR N/A
  • AVPT N/A
  • Revenue
  • NVCR $549,964,000.00
  • AVPT $299,879,000.00
  • Revenue This Year
  • NVCR $16.23
  • AVPT $21.04
  • Revenue Next Year
  • NVCR $6.09
  • AVPT $17.26
  • P/E Ratio
  • NVCR N/A
  • AVPT N/A
  • Revenue Growth
  • NVCR 8.33
  • AVPT 19.57
  • 52 Week Low
  • NVCR $10.87
  • AVPT $7.08
  • 52 Week High
  • NVCR $24.74
  • AVPT $12.67
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • AVPT 61.51
  • Support Level
  • NVCR $15.61
  • AVPT $11.92
  • Resistance Level
  • NVCR $17.31
  • AVPT $12.18
  • Average True Range (ATR)
  • NVCR 1.29
  • AVPT 0.30
  • MACD
  • NVCR 0.05
  • AVPT -0.00
  • Stochastic Oscillator
  • NVCR 11.59
  • AVPT 79.62

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About AVPT AvePoint Inc.

AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.

Share on Social Networks: